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The protective effect of corticosteroids against the lethal effect of high doses
of bacterial endotoxins (LPS) has been known since 1954 (1-3), and it is also
acknowledged that adrenalectomized animals are more sensitive to the lethal
effect of LPS (3, 4). In this respect, the protective effect ofcorticosteroids could
be exerted at many sites. It has been suggested that inhibition of the activity of
the reticuloendothelial system by corticosteroids might be important in their
pharmacological effect (5). Recent studies have indicated that most ofthe in vivo
effects of LPS are probably mediated by LPS-induced monocyte products, the
attention having been focused on two of them in particular, IL-1 and TNF. IL-
1 was originally described as the LPS-induced leukocytic pyrogen (6), and TNF
as the LPS-induced mediator responsible for the antitumor and toxic (7) effects
of LPS. Tracy et al. (8) recently suggested that TNF might have an important
role in LPS-induced shock, and showed that rTNF can induce shock in rats,
while passive immunization against TNF protected against the lethal effect of
LPS (9). More recently, rIL-1 was also reported to induce hemodynamic shock
in rabbits (10). The finding that corticosteroids are potent inhibitors of the syn-
thesis of IL-1 and TNF in macrophages (11-13) has cast fresh light on the mech-
anisms underlying the protective effect of corticosteroids against LPS, suggest-
ing that inhibition of synthesis of these toxic mediators might be important in
the anti-LPS properties ofcorticosteroids. In addition to this general inhibitory
effect of corticosteroids on monokine synthesis, other interregulatory relation-
ships between corticosteroids and monokines were reported. For instance, IL-1
was shown to influence glucocorticoid-regulated metabolism (14), to induce
release of corticosteroids in plasma by stimulating the release of adrenocorti-
cotrophic hormone (15), and to potentiate the synthesis of some acute-phase
proteins (16). Therefore, we have investigated the effect of adrenalectomy on
the susceptibility to the lethal effects of LPS, TNF, and IL-1 .
Materials and Methods
BriefDefinitive Report
Male, adult (25-30 g) CD-1 mice (Charles River Breeding Laboratories, Calco, Italy)
were used. Adrenalectomy was performed under ether anesthesia 10 d before the exper-
iment. Adrenalectomized mice were given 1 % (wt/vol) sodium chloride in drinking water.
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Animals were housed five per cage in air-conditioned quarters (60% relative humidity,
22°C) with a 12-h light/dark cycle, and were given standard laboratory chow (Altromin,
Rieper, Bolzano, Italy). The endotoxin used was Escherichia coli LPS, serotype 055:115.
(Sigma Chemical Co., St. Louis, MO).
Human rIL-la was a kind gift from Dr. PeterT. Lomedico, Hoffmann-La Roche, Inc.,
Nutley, NJ. Human rTNF-a was a kind gift from Dr. Leo S. Lin, Cetus Corp., Emeryville,
CA. Murine rTNF (17) was prepared as previously described (18) and obtained through
the courtesy of Dr. J. Tavernier, Biogent, Belgium. Dexamethasone phosphate (Solde-
sam) was from Farmacologico Milanese s.p.a., Milano, Italy. Ibuprofen (Artrene) was
from IRBI, Pomezia, Roma, Italy.
Results
Table I shows the lethality of LPS, human and murine TNF, and IL-1 in adre-
nalectomized mice. No mortality was observed when the same doses of LPS,
TNF, or IL-1 were administered to control or sham-operated mice (data not
shown), or when adrenalectomized mice were given heat-inactivated (90°C, 30
min) TNF or IL-1 (data not shown), indicating that lethality was not due to
endotoxin contamination of the genetically engineered proteins. It can be noted
that TNF (both human and murine) proved to be consistently less toxic, on a
weight basis, than IL-1 or LPS.
Complete protection against the lethal effect of LPS, TNF, or IL-1 was
achieved when dexamethasone (DEX) was administered at the dose of 30 mg/
Kg, intraperitoneally, 30 min before LPS, TNF, or IL-1 (Table II). In an attempt
to define whether a high dose of DEX was required for the protective effect,
we gave adrenalectomized mice different doses (30, 3, 0.3, and 0.03 mg/Kg) 30
min before injection of 75 Ag/Kg of LPS. The lowest effective dose that com-
pletely prevented the lethal effect of LPS was 0.3 mg/Kg (data not shown) . No
protection was observed when adrenalectomized mice were pretreated with the
TABLE I
Lethality ofLPS, TNF, and IL-1 in Adrenalectomized Mice
* Number dead/number treated; all deaths occurred within 24 h. Mice
were monitored for 1 wk before terminating the experiment.
Treatment Dose (i.v.) Mortality* (%)
wgIKg
LPS 75 10/1o(100)
30 10/1o(100)
3 1/5 (20)
0 .3 0/5 (0)
Human TNF 75 6/l0 (60)
30 5/19 (26)
7.5 0/l0 (0)
Murine TNF 150 6/l0 (60)
75 2/12 (17)
IL-1 30 7/10 (70)
7.5 3/5 (60)
3.0 0/5 (0)1710
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TABLE II
Protective Effect ofDexamethasone Against theLethal Effect ofLPS,
TNF, or IL-1 in Adrenalectomized Mice
* Number dead/number treated.
t X 30 wg/Kg i.v.
§ DEXwas given at the dose of 30 mg/Kgi.p., 30 min before treatment.
cyclooxygenase inhibitor ibuprofen (30 mg/Kg, i.p., data not shown), which was
previously reported to protect against the lethality of high-dose LPS (20 mg/Kg)
in normal (nonadrenalectomized) rats and against IL-1-induced hemodynamic
shock, suggesting that ibuprofen is not as potent as DEX.
Discussion
While the increased sensitivity of adrenalectomized animals to the lethal effect
of LPS has already been described, this is the first report on the sensitizing
effect of adrenalectomy on the lethality of rTNF or rIL-1 at doses that are nor-
mally well tolerated in control or sham-operated mice. This extends the list of
the effects of LPS that can be mimicked by TNF or IL-1 . With respect to the
lower toxicity of TNF (both human and murine), when compared with IL-1 or
LPS, in adrenalectomized mice, it is important to remember that in judging the
relative "potency" of a protein in an in vivo system, many factors might influ-
ence the results, including pharmacokinetics and disposition of the protein
administered.
The protective effect of DEX in this experimental model is not surprising in
view of previous data on LPS toxicity. On the other hand, the fact that adre-
nalectomy increases the toxicity of IL-1, not only of TNF, clearly indicates that
the protective effect of corticosteroids on endotoxic shock cannot be explained
merely by their inhibition of LPS induction of these monokines usually consid-
ered as the mediators of LPS toxicity. In fact, while corticosteroids antagonize
the toxic effect of LPS and the synthesis of LPS-induced monokines, they poten-
tiate the synthesis of many acute-phase proteins (16, 19), and this might be
important in their pharmacological action, in view of the fact that most of the
acute-phase proteins induced by LPS have detoxifying and anti-LPS (or anti-
shock) activities. For instance, angiotensinogen, which is important in the main-
tenance of blood pressure and electrolyte homeostasis, was reported to be
increased in vivo, after LPS and glucocorticoids, to be required for its induc-
tion, not observed in adrenalectomized mice (19) . Therefore, the protective
effect of dexamethasone, and the increased sensitivity of adrenalectomized mice
on IL-1 and TNF toxicity might be due either to a direct hemodynamic effect
Mortality*
Treatment'
Without DEX (%) With DEX§ (%)
I.PS 5/5 (100) 0/5 (0)
Human TNF 2/5(40) 0/5(0)
IL-1 4/5(80) 0/5(0)BERTINI ET AL.
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of glucocorticoids or to their "permissive" action on the induction of protective
acute-phase proteins.
While it was known that high-dose TNF can be lethal, to our knowledge, no
lethality has ever been reported with IL-1, and our finding in adrenalectomized
mice supports the report by Okusawa et al. (10) that IL-1 induces hemodinamic
shock and that, therefore, IL-1, not only TNF, might be important in the lethal-
ity of LPS.
Summary
To clarify the possible role of TNF and IL-1 in endotoxic shock, the lethality
of rTNF (human and murine) and IL-1 in adrenalectomized mice was studied.
Adrenalectomy, which has long been known to increase the susceptibility to
endotoxin, rendered mice susceptible to TNF and IL-1 in terms of mortality.
The lethality of endotoxin, TNF, or IL-1 was totally prevented by pretreatment
with dexamethasone (minimal effective dose, 0.3 mg/Kg) but not by ibuprofen
(10 mg/Kg) .
We thank Dr. A. Mantovani for helpful discussion and critical revision of this manuscript,
and Dr. J. Tavernier, Biogen (Cambridge, MA), for providing us with mouse rTNF.
Received for publication 17 December 1987.
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